NCT02494141View on ClinicalTrials.gov

Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 12, 2015

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG

Curcumin

Dietary Supplement

OTHER

Placebo

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02494141 - Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD | Biotech Hunter | Biotech Hunter